Virtus ETF Advisers’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
FLAM
TCM
BCM
SI
Virtus ETF Advisers's ANAB Position: Q1 2025 in Review
Virtus ETF Advisers sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 4,733 shares — an estimated $62.7K sold.
Virtus ETF Advisers first reported a position in ANAB in Q2 2019 and held it in 23 quarters. The position peaked at $426K in Q4 2019. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.
- Virtus ETF Advisers reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
- Virtus ETF Advisers sold 4,733 AnaptysBio shares in Q1 2025, an estimated $62.7K.
- Virtus ETF Advisers first reported a position in AnaptysBio in Q2 2019 and held it in 23 quarters.
- Virtus ETF Advisers's AnaptysBio position peaked at $426K in Q4 2019.
- 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.
Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.